Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

After years of weight loss drug shortages, the FDA is saying there's now an adequate supply for most medications and they ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

The Danish drugmaker has launched a new online pharmacy called NovoCare Pharmacy to cut out the middlemen it so frequently ...